Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Eva M. Szegö"'
Autor:
Lennart Höfs, David Geißler-Lösch, Kristof M. Wunderlich, Eva M. Szegö, Chris Van den Haute, Veerle Baekelandt, Wolfgang Hoyer, Björn H. Falkenburger
Publikováno v:
Biomolecules, Vol 14, Iss 7, p 756 (2024)
Aggregation of the protein α-Synuclein (αSyn) is a hallmark of Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple systems atrophy, and alleviating the extent of αSyn pathology is an attractive strategy against neurodegenerati
Externí odkaz:
https://doaj.org/article/56e384f27b224c169fcf2c4f39ceedc3
Autor:
Anke Van der Perren, Veerle Baekelandt, Björn H. Falkenburger, Lennart Höfs, Chris Van Den Haute, Eva M. Szegö
Publikováno v:
Experimental neurology 347, 113900 (2022). doi:10.1016/j.expneurol.2021.113900
Experimental neurology 347, 113900 (2022). doi:10.1016/j.expneurol.2021.113900
Published by Elsevier, Amsterdam[u.a.]
Published by Elsevier, Amsterdam[u.a.]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05b397acfc3516ae9446415578af5ec
Autor:
Elisabeth Dinter, Diana Cozma, Björn H. Falkenburger, Theodora Saridaki, Eva M. Szegö, Anna Maria Hilverling
Publikováno v:
Cellular and Molecular Neurobiology
Cellular and molecular neurobiology 42(1), 155-171 (2022). doi:10.1007/s10571-021-01116-0
Cellular and molecular neurobiology 42, 155-171 (2022). doi:10.1007/s10571-021-01116-0
Cellular and molecular neurobiology 42(1), 155-171 (2022). doi:10.1007/s10571-021-01116-0
Cellular and molecular neurobiology 42, 155-171 (2022). doi:10.1007/s10571-021-01116-0
Cellular and molecular neurobiology 42, 155-171 (2022). doi:10.1007/s10571-021-01116-0
Published by Springer Science + Business Media B.V, Dordrecht
Published by Springer Science + Business Media B.V, Dordrecht
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85b5010f448c6f241c94a7823fe27b1c
Autor:
Éva M. Szegõ, Eva M. Szegö, Chris Van den Haute, Lennart Höfs, Veerle Baekelandt, Anke Van der Perren, Björn Falkenburger
BackgroundDuring the pathogenesis of Parkinson’s disease (PD), aggregation of alpha-synuclein (αSyn) induces a vicious cycle of cellular impairments that lead to neurodegeneration. Consequently, removing toxic αSyn aggregates constitutes a plausi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34bccabb3610338904d24cf958eb45a3
https://doi.org/10.21203/rs.3.rs-277472/v1
https://doi.org/10.21203/rs.3.rs-277472/v1
Autor:
Michael M. Wördehoff, Wolfgang Hoyer, Charlott Gärtner, Theodora Saridaki, Daniel Komnig, Eva M. Szegö, Fabian Boß, Éva M. Szegő, Hamed Shaykhalishahi, Lennart Höfs, Björn H. Falkenburger, Jörg B. Schulz
Background Removing α-synuclein aggregates or preventing their formation constitutes a plausible strategy against Parkinson’s disease (PD). As we recently demonstrated, the β-wrapin protein AS69 binds an N-terminal region in monomeric α-synuclei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f97f05f5b74d233b2ed4ae2132f2075
https://doi.org/10.21203/rs.3.rs-41606/v1
https://doi.org/10.21203/rs.3.rs-41606/v1
Autor:
Priyanka Bhatia, Marc Bickle, Amay A. Agrawal, Buster Truss, Aikaterina Nikolaidi, Kathrin Brockmann, Lydia Reinhardt, Stefanie Vogel, Eva M. Szegoe, Arun Pal, Andreas Hermann, Ivan Mikicic, Maximina Yun, Björn Falkenburger, Jared Sterneckert
Publikováno v:
Biology, Vol 13, Iss 1, p 58 (2024)
The degeneration of axon terminals before the soma, referred to as “dying back”, is a feature of Parkinson’s disease (PD). Axonal assays are needed to model early PD pathogenesis as well as identify protective therapeutics. We hypothesized that
Externí odkaz:
https://doaj.org/article/4952ffb943c34abcbcc6ad2a203b9ec1
Autor:
Éva M. Szegő, Fabian Boß, Daniel Komnig, Charlott Gärtner, Lennart Höfs, Hamed Shaykhalishahi, Michael M. Wördehoff, Theodora Saridaki, Jörg B. Schulz, Wolfgang Hoyer, Björn H. Falkenburger
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
Reducing α-synuclein pathology constitutes a plausible strategy against Parkinson’s disease. As we recently demonstrated, the β-wrapin protein AS69 binds an N-terminal region in monomeric α-synuclein, interferes with fibril nucleation, and reduc
Externí odkaz:
https://doaj.org/article/4afc3502a31946d28cb7ee107aa29503
Autor:
Isabel Paiva, Gaurav Jain, Diana F. Lázaro, Kristina Gotovac Jerčić, Thomas Hentrich, Cemil Kerimoglu, Raquel Pinho, Èva M. Szegő, Susanne Burkhardt, Vincenzo Capece, Rashi Halder, Rezaul Islam, Mary Xylaki, Lucas A. Caldi Gomes, Anna-Elisa Roser, Paul Lingor, Julia M. Schulze-Hentrich, Fran Borovečki, André Fischer, Tiago F. Outeiro
Publikováno v:
Neurobiology of Disease, Vol 119, Iss , Pp 121-135 (2018)
Alpha-synuclein (aSyn) is the major protein component of Lewy bodies and Lewy neurites, the typical pathological hallmarks in Parkinson's disease (PD) and Dementia with Lewy bodies. aSyn is capable of inducing transcriptional deregulation, but the pr
Externí odkaz:
https://doaj.org/article/75ce3a76847041c5a470e50f98fcc59a
Autor:
Éva M. Szegő, Antonio Dominguez-Meijide, Ellen Gerhardt, Annekatrin König, David J. Koss, Wen Li, Raquel Pinho, Christiane Fahlbusch, Mary Johnson, Patricia Santos, Anna Villar-Piqué, Tobias Thom, Silvio Rizzoli, Matthias Schmitz, Jiayi Li, Inga Zerr, Johannes Attems, Olaf Jahn, Tiago F. Outeiro
Publikováno v:
Cell Reports, Vol 28, Iss 1, Pp 65-77.e6 (2019)
Summary: Alpha-synuclein (aSyn) accumulates in intracellular inclusions in synucleinopathies, but the molecular mechanisms leading to disease are unclear. We identify the 10 kDa heat shock protein (HSP10) as a mediator of aSyn-induced mitochondrial i
Externí odkaz:
https://doaj.org/article/4a2e2c417fdf4144aa56a9b613fab5a7
Autor:
Kim-Ann Saal, Jan C. Koch, Lars Tatenhorst, Éva M. Szegő, Vinicius Toledo Ribas, Uwe Michel, Mathias Bähr, Lars Tönges, Paul Lingor
Publikováno v:
Neurobiology of Disease, Vol 73, Iss , Pp 150-162 (2015)
Parkinson's disease (PD) is a neurodegenerative disorder with prominent neuronal cell death in the substantia nigra (SN) and other parts of the brain. Previous studies in models of traumatic and neurodegenerative CNS disease showed that pharmacologic
Externí odkaz:
https://doaj.org/article/c2113aec27f04b79a88c4f5f1bf73ef8